Novartis AG (NVS)
152.06
-1.75
(-1.14%)
USD |
NYSE |
Aug 31, 16:00
152.06
0.00 (0.00%)
After-Hours: 20:00
Novartis Total Long Term Debt (Quarterly) : 39.43B for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 39.43B |
| March 31, 2026 | 39.38B |
| December 31, 2025 | 30.65B |
| September 30, 2025 | 24.50B |
| June 30, 2025 | 24.32B |
| March 31, 2025 | 23.47B |
| December 31, 2024 | 26.52B |
| September 30, 2024 | 25.59B |
| June 30, 2024 | 21.46B |
| March 31, 2024 | 18.94B |
| December 31, 2023 | 22.46B |
| September 30, 2023 | 19.73B |
| June 30, 2023 | 20.05B |
| March 31, 2023 | 22.24B |
| December 31, 2022 | 24.27B |
| September 30, 2022 | 21.48B |
| June 30, 2022 | 24.04B |
| March 31, 2022 | 24.64B |
| December 31, 2021 | 27.42B |
| September 30, 2021 | 24.99B |
| June 30, 2021 | 26.77B |
| March 31, 2021 | 27.68B |
| December 31, 2020 | 30.54B |
| September 30, 2020 | 28.45B |
| June 30, 2020 | 25.91B |
| Date | Value |
|---|---|
| March 31, 2020 | 25.74B |
| December 31, 2019 | 24.30B |
| September 30, 2019 | 22.10B |
| June 30, 2019 | 22.41B |
| March 31, 2019 | 23.16B |
| December 31, 2018 | 25.66B |
| September 30, 2018 | 22.60B |
| June 30, 2018 | 22.76B |
| March 31, 2018 | 23.20B |
| December 31, 2017 | 23.58B |
| September 30, 2017 | 23.16B |
| June 30, 2017 | 23.00B |
| March 31, 2017 | 22.93B |
| December 31, 2016 | 18.08B |
| September 30, 2016 | 18.26B |
| June 30, 2016 | 16.28B |
| March 31, 2016 | 16.46B |
| December 31, 2015 | 17.99B |
| September 30, 2015 | 13.41B |
| June 30, 2015 | 13.30B |
| March 31, 2015 | 14.83B |
| December 31, 2014 | 16.79B |
| September 30, 2014 | 12.67B |
| June 30, 2014 | 12.87B |
| March 31, 2014 | 15.20B |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Roche Holding AG | 0.00 |
| AstraZeneca PLC | 30.91B |
| Johnson & Johnson | 37.34B |
| Eli Lilly & Co. | 49.62B |
| Merck & Co., Inc. | 51.08B |